Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial.
Young G, Srivastava A, Kavakli K, Ross C, Sathar J, You CW, Tran H, Sun J, Wu R, Poloskey S, Qiu Z, Kichou S, Andersson S, Mei B, Rangarajan S. Young G, et al. Among authors: rangarajan s. Lancet. 2023 Apr 29;401(10386):1427-1437. doi: 10.1016/S0140-6736(23)00284-2. Epub 2023 Mar 29. Lancet. 2023. PMID: 37003287 Clinical Trial.
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial.
Srivastava A, Rangarajan S, Kavakli K, Klamroth R, Kenet G, Khoo L, You CW, Xu W, Malan N, Frenzel L, Bagot CN, Stasyshyn O, Chang CY, Poloskey S, Qiu Z, Andersson S, Mei B, Pipe SW. Srivastava A, et al. Among authors: rangarajan s. Lancet Haematol. 2023 May;10(5):e322-e332. doi: 10.1016/S2352-3026(23)00037-6. Epub 2023 Mar 29. Lancet Haematol. 2023. PMID: 37003278 Clinical Trial.
Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India.
Bansal S, Donners AAMT, Fischer K, Kshirsagar S, Rangarajan S, Phadke V, Mhatre S, Sontate B, Silva M, Ansari S, Shetty S. Bansal S, et al. Among authors: rangarajan s. Haemophilia. 2023 May;29(3):931-934. doi: 10.1111/hae.14785. Epub 2023 Apr 8. Haemophilia. 2023. PMID: 37029771 No abstract available.
Implementation of a gene therapy education initiative by the ASGCT and Muhimbili University of Health and Allied Sciences.
Cornetta K, Kay S, Urio F, Minja IK, Mbugi E, Mgaya J, Mselle T, Nkya S, Alimohamed MZ, Ndaki K, Bonamino M, Koya RC, Shah LD, Mahlangu J, Drago D, Rangarajan S, Jayandharan GR. Cornetta K, et al. Among authors: rangarajan s. Mol Ther. 2023 Sep 6;31(9):2561-2565. doi: 10.1016/j.ymthe.2023.07.019. Epub 2023 Aug 17. Mol Ther. 2023. PMID: 37595584
The translational gap for gene therapies in low- and middle-income countries.
Doxzen KW, Adair JE, Fonseca Bazzo YM, Bukini D, Cornetta K, Dalal V, Guerino-Cunha RL, Hongeng S, Jotwani G, Kityo-Mutuluuza C, Lakshmanan K, Mahlangu J, Makani J, Mathews V, Ozelo MC, Rangarajan S, Scholefield J, Batista Silva Júnior J, McCune JM. Doxzen KW, et al. Among authors: rangarajan s. Sci Transl Med. 2024 May 8;16(746):eadn1902. doi: 10.1126/scitranslmed.adn1902. Epub 2024 May 8. Sci Transl Med. 2024. PMID: 38718130 Review.
Physical Activity and Obesity Risk in Adults in Colombia: The Prospective Urban Rural Epidemiology (PURE) Study.
O'Donovan G, Martínez D, López-López JP, Otero J, Urina M, Vasquez T, Niño M, Narvaez C, Campo MC, Perez-Mayorga M, Rodríguez S, Arcos E, Sanchez G, García H, Rangarajan S, Yusuf S, López-Jaramillo P. O'Donovan G, et al. Among authors: rangarajan s. Med Sci Sports Exerc. 2024 Feb 24. doi: 10.1249/MSS.0000000000003413. Online ahead of print. Med Sci Sports Exerc. 2024. PMID: 38648672
Influence of age and sex on physical, cardiac electrical and functional alterations in progressive hyperoxia treatment: A time course study in a murine model.
Ayalasomayajula Y, Hesaraghatta A, Dantuluri N, Yassine J, Saleem F, Mansour H, Chayawatto C, Rangarajan N, Rangarajan S, Krishnan S, Panguluri SK. Ayalasomayajula Y, et al. Among authors: rangarajan s. Exp Gerontol. 2024 Apr 19;191:112435. doi: 10.1016/j.exger.2024.112435. Online ahead of print. Exp Gerontol. 2024. PMID: 38636569 Free article.
Associations of perceived built environment characteristics using NEWS questionnaires with all-cause mortality and major cardiovascular diseases: The prospective urban rural epidemiology (PURE)-China study.
Li M, Li Y, Liu Z, Hystad P, Rangarajan S, Tse LA, Lear SA, Ma Y, Chen M, Han G, Li R, Yusuf S, Liu L, Hu B, Li W; PURE-China Investigators. Li M, et al. Among authors: rangarajan s. Environ Int. 2024 Apr 13;187:108627. doi: 10.1016/j.envint.2024.108627. Online ahead of print. Environ Int. 2024. PMID: 38636273 Free article.
Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study.
Miller V, Jenkins DA, Dehghan M, Srichaikul K, Rangarajan S, Mente A, Mohan V, Swaminathan S, Ismail R, Luz Diaz M, Ravindran RM, Zatonska K, Bahonar A, Altuntas Y, Khatib R, Lopez-Jaramillo P, Yusufali A, Yeates K, Chifamba J, Iqbal R, Yusuf R, Catherina Swart E, Bo H, Han G, Li X, Alhabib KF, Rosengren A, Avezum A, Lanas F, Yusuf S; Prospective Urban and Rural Epidemiology (PURE) study investigators. Miller V, et al. Among authors: rangarajan s. Lancet Diabetes Endocrinol. 2024 May;12(5):330-338. doi: 10.1016/S2213-8587(24)00069-X. Epub 2024 Apr 5. Lancet Diabetes Endocrinol. 2024. PMID: 38588684
524 results